The archive
Every edition, every check.
Each day's edition as it ran, re-verified, with its cartoons. Members read every story in full; sources and corrections stay open to everyone.
Every story, page 11
- TRUE, BUT · Lab Not FieldOpenAI and Anthropic are selling the same next step for AI agents: more of them. Claude Code now forks subagents by default, and Sol Ultra fans a problem across up to 64. Google Research ran the controlled test, and the answer is a split: more agents help work that breaks into independent pieces and hurt work that runs as one dependent chain, by up to 70%. Which one your task is decides whether the swarm is an upgrade or a tax.
- TRUE, BUT · Moved RulerThe coding number everyone quotes says AI has nearly solved software engineering: Claude Opus 5 scores 96% on SWE-bench Verified. Move to the benchmark built to resist contamination and the top model sits at 80.3%, and GPT-5.6 Sol lands at 64.6%.
AI illustration - TRUE, BUT · The AnnualiserAnthropic is pitching investors a $2 trillion IPO built on a revenue forecast that requires 4.3x growth in under two years, from a company that posted its first quarterly profit three months ago on a discounted compute bill.
AI illustration 
AI illustration 
AI illustration 
AI illustration - TRUE, BUT · Zero UnderneathA rocket company paid $60 billion in its own stock for a code editor. Cursor's revenue has never been publicly disclosed. The deal closed on August 14, making it the year's largest startup acquisition, and Cursor now claims access to the largest fleet of GPUs in the world, a fleet nobody outside SpaceX can count.
- TRUE, BUT · Human In The LoopThe first AI boss fired a human this week. It had to be told its own rules first, and a human held the axe.
- TRUE, BUT · Zero Underneath101,743 job-cut announcements cited AI as the reason. New York gave companies the option to cite AI on layoff filings. Zero did.
- VERIFIEDAnthropic's CEO now admits 'the most accurate criticism of AI companies including Anthropic is that we haven't yet delivered on our big promises.' He called 'cure cancer' a cliche.
